(Q34993894)

English

Lixisenatide, a novel GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus

scientific article

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

5 August 2017

1 reference

Europe PubMed Central

title

Lixisenatide, a novel GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus (English)

1 reference

stated in

Europe PubMed Central

5 August 2017

0 references

1 reference

ChEBI release 2020-05-28

3

0 references

author name string

Mikkel Christensen

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed ID

19629885

retrieved

5 August 2017

Filip K Knop

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed ID

19629885

retrieved

5 August 2017

Tina Vilsboll

series ordinal

4

1 reference

stated in

Europe PubMed Central

5 August 2017

1 August 2009

1 reference

stated in

Europe PubMed Central

5 August 2017

IDrugs: the Investigational Drugs Journal

1 reference

stated in

Europe PubMed Central

5 August 2017

12

1 reference

stated in

Europe PubMed Central

5 August 2017

8

1 reference

stated in

Europe PubMed Central

5 August 2017

503-513

1 reference

stated in

Europe PubMed Central

PubMed ID

19629885

retrieved

5 August 2017

Identifiers

PubMed ID

19629885

1 reference

stated in

Europe PubMed Central

PubMed ID

19629885

retrieved

5 August 2017

(Q34993894)

Lixisenatide, a novel GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)